DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/b45x6x/squamous) has announced the addition of the "Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic development for Squamous Non-Small Cell Lung Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Squamous Non-Small Cell Lung Cancer and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Companies Involved in Therapeutics Development
- AbbVie Inc.
- Advenchen Laboratories, LLC
- Ascenta Therapeutics, Inc.
- AstraZeneca Plc
- AVEO Pharmaceuticals, Inc.
- Bayer AG
- BIND Therapeutics, Inc.
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- Five Prime Therapeutics, Inc.
- Genentech, Inc.
- Incyte Corporation
- Johnson & Johnson
- MacroGenics, Inc.
- Novartis AG
- Oncogenex Pharmaceuticals, Inc.
- PsiOxus Therapeutics Limited
- Vertex Pharmaceuticals Incorporated
Drug Profiles
- abemaciclib
- ABT-414
- apatorsen
- AT-406
- atezolizumab
- AV-203
- AZD-2014
- AZD-8186
- BAY-1163877
- BMS-906024
- buparlisib hydrochloride
- docetaxel
- enadenotucirev
- enoblituzumab
- FP-1039
- iMDK
- INCB-54828
- ipilimumab
- JNJ-42756493
- lucitanib
- LY-3023414
- necitumumab
- nintedanib
- prexasertib
- Small Molecule to Inhibit TWIST1 for Non-Small Cell Lung Cancer
- taselisib
- veliparib
- VX-970
For more information visit http://www.researchandmarkets.com/research/b45x6x/squamous
